PMV PHARMACEUTICALS, INC. Cash Equivalents, at Carrying Value
PMV PHARMACEUTICALS, INC. (PMVP) had Cash Equivalents, at Carrying Value of $12.47 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash Equivalents, at Carrying Value $12.47M.
- 2026-03-31: Cash Equivalents, at Carrying Value $39.04M.
- 2025-12-31: Cash Equivalents, at Carrying Value $37.98M; Cash Equivalents, at Carrying Value as first filed $37.89M.
- 2025-09-30: Cash Equivalents, at Carrying Value $36.34M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $12.47M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $39.04M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $37.98M 10-Q · filed 2026-08-14 | $37.89M 10-K · filed 2026-03-06 |
| 2025-09-30 | $36.34M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $44.13M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $51.34M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $40.88M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $48.81M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $48.53M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $47.65M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $37.71M 10-K · filed 2025-03-03 | $37.69M 10-K · filed 2024-02-29 |
| 2023-09-30 | $51.80M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $64.69M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $136.89M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $106.86M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $98.35M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $83.77M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $114.27M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $168.96M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $174.69M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $185.90M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $207.80M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $360.04M 10-K · filed 2022-03-01 | $360.00M 10-K · filed 2021-03-03 |
| 2020-09-30 | $141.20M 10-Q · filed 2020-11-13 | |
| 2019-12-31 | $71.30M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |